Abstract:Human cerebrospinal fluid (CSF), produced by the choroid plexus and secreted into the brain ventricles and subarachnoid space, plays critical roles in intra-cerebral transport and the biophysical and immune protection of the central nervous system (CNS). CSF composition provides valuable insight into soluble pathogenic bio-markers that may be diagnostic for neurodegenerative disease. In these experiments we analyzed amyloid beta (Aβ) peptide and micro RNA (miRNA) abundance (i) in CSF, (ii) in short post-mortem interval brain tissue-derived extracellular fluid (ECF) and (iii) in brain tissue biopsy derived from Alzheimer's disease (AD) or age-matched control neocortex and/or hippocampal CA1. 3'-untranslated region (3'-UTR) sequence/vector analysis; Aβ42-peptide+TNFα-induced and/or hydrogen peroxide-induced stress; bioinformatics; CAPE, CAY10512, DNA array; DNA/RNA sequencing; human brain biopsy/postmortem tissue; human CSF;LED-Northern micro-dot blot analysis; micro-RNA array; protected anti-miRNAs; RT-PCR; statistical analysis, β-actin, TREM-2- and CFH-3'-UTR-luciferase-reporter transfection assay; UV/fluorescent microscopy; Western immuno-histochemistry. There was a trend for decreased-abundance of Aβ42 in the CSF and ECF in AD but it did not reach statistical significance (mean-age ∼72 yr; N=12; p∼0.06, ANOVA). The most abundant nucleic acids in AD-CSF and ECF were miRNAs and their speciation, abundance and inducibility were studied further. Comparison of miRNA signals between biopsy and post-mortem tissues (0.5–6 hrs) indicated a short half-life for many brain-enriched miRNAs. Fluorescent miRNA-array-based analysis indicated significant increases in miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155. Increases in miRNAs were confirmed independently using a highly-sensitive LED-Northern dot-blot assay. Primary human neuronal-glial cell co-cultures stressed with AD-derived ECF, TNFα or peroxide also displayed an up-regulation of these and other miRNAs. These effects were quenched using the anti-NF-КB agents caffeic acid-phenethyl-ester (CAPE) or 1-fluoro-2-[2-(4-methoxy-phenyl)-ethenyl]-benzene (CAY10512). The results indicate that miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155 are a family of inducible, NF-КB-sensitive pro-inflammatory miRNAs that are abundant in AD tissues and fluids. These AD-upregulated miRNAs further associate with deficits in the innate-immune response and the chronic and progressive spreading of inflammatory neurodegeneration. Enrichment of these miRNAs in circulating CSF and ECF suggest that they may be involved in the proliferation of miRNA-triggered pathogenic signaling throughout the AD brain and CNS.

Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer's disease.

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

An in silico approach to identify potential downstream targets of miR-153 involved in Alzheimer's disease

Primate specific miR 603 is implicated in the risk and pathogenesis of Alzheimer's disease

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

Microrna-34A (Mirna-34A) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)

MicroRNAs 99B-5P/100-5p Regulated by Endoplasmic Reticulum Stress Are Involved in Abeta-Induced Pathologies.

microRNA‐425 loss mediates amyloid plaque microenvironment heterogeneity and promotes neurodegenerative pathologies

MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects

Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer’s Disease Mice

miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease

miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease

Analysis of Serum miRNAs in Alzheimer's Disease.

MicroRNA Mir-103A-3p Targets NPAS3 to Regulate Progression of Alzheimer’s Disease

Upregulation of Micro RNA (mirna) Signaling in Alzheimer's Disease (AD) and Related Neurological Disorders

MiR-137-3p Mechanisms of Action and Blood-Brain Barrier Penetrating and Neuron-Targeting Lipid Nanoparticles Deliver Mir-137-3p for the Treatment of Alzheimer's Disease

MicroRNA Complexity in Alzheimer's Disease Cerebrospinal Fluid, Extracellular Fluid and Brain Tissue Biopsy

Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer’s Disease

Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease